Increasing the Understanding of Disease Proteins Recognized by Antibodies Should Accelerate Development of Optimized Drugs, Vaccines, and Diagnostics Across Diseases and Conditions from Cancers to Crohn’s and Transplant Rejections to Neurodegenerative Diseases SOUTH EASTON, MA / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of pressure-based instruments and platform technologies […]
Cambridge, UK – Abcam, a global innovator in life science reagents and tools, is pleased to announce its move to new state-of-the-art global headquarters, Discovery Drive, on the Cambridge Biomedical Campus (CBC), UK, a leading hub of healthcare, science and medical research. Alan Hirzel, CEO, Abcam, commented: “Abcam has been working for 20 years providing […]
Brings Decades of Leadership Experience in Biopharmaceutical Analytical Instrumentation NEWARK, Calif. — Intabio, Inc. today announced the appointment of Rohit Khanna to its Board of Directors. In 2017, Dr. Khanna concluded a highly-successful career at Waters Corporation, where he most recently served as Senior Vice President and Corporate Officer with direct responsibility for over $1.1B in Waters’ Applied Technology Businesses. Dr. Khanna […]
High-Potential Ocular Research Applications Extend to Dry Eye & Beyond WATERLOO, Ontario—The Centre for Ocular Research & Education (CORE) has announced an initiative to advance use of the Meso Scale Discovery® (MSD) platform to identify biomarkers in the tear film, expanding ocular health diagnoses and treatment options. Hundreds of proteins are found in the tear film, and their levels fluctuate […]
WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”) announced today that it has entered into a definitive agreement with General Electric Company (“GE”) (NYSE: GE) to acquire the Biopharma business of GE Life Sciences (“GE Biopharma”) for a cash purchase price of approximately $21.4 billion. Given anticipated tax benefits from the transaction structure, the net […]
Partnership will leverage BenchSci’s AI to help scientists find the right reagents and enable ABclonal to compete on product quality BOSTON — ABclonal Technology, a new and growing provider of biology research reagents and services, and BenchSci, a life science machine learning company backed by Google’s AI fund, have entered into a partnership to provide […]
Partnership targets broader availability of new models and tools for cancer research CAMBRIDGE, Mass. — Cellaria, LLC, a scientific innovator that develops revolutionary new models for cancer and other diseases, today announced a new distribution partnership with Rockland Immunochemicals, Inc. (Rockland), a life science supplier and manufacturer that specializes in antibodies and antibody-based tools for research applications […]
VICTORIA – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) has received a five-year Indefinite Delivery/Indefinite Quantity (ID/IQ) subcontract from Leidos Biomedical Research, Inc., which currently operates the Frederick National Laboratory for Cancer Research for the National Cancer Institute (NCI). Under the subcontract, IPA will discover and produce rabbit monoclonal antibodies […]
For a few years now, molecular biology has been completely dominated by single cell technologies. It all started with single cell RNA-Seq, but rapidly branched out to other applications, such as epigenomics, regulation (ATAC-Seq and ChIP-Seq), and proteomics (for a high-level overview, we suggest an excellent recent articlein Nature Reviews Genetics). Analysis of single cell data sets […]
New REAlease® Fluorochrome Technology available BERGISCH GLADBACH, February 21, 2019 – The new REAlease® Releasable Antibodies from Miltenyi Biotec are based on the ground-breaking REAlease® Fluorochrome Technology and allow for the removal of antibodies after cell sorting in just one step. Sorted cells are label-free to provide maximal flexibility in downstream applications. Multicolor flow cytometry-based cell sorting is the method of […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
